| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |